chr17-10392944-G-C

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_002472.3(MYH8):​c.5350C>G​(p.Arg1784Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00729 in 1,614,100 control chromosomes in the GnomAD database, including 62 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1784W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0047 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0076 ( 59 hom. )

Consequence

MYH8
NM_002472.3 missense

Scores

6
9
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:7

Conservation

PhyloP100: 0.467

Publications

9 publications found
Variant links:
Genes affected
MYH8 (HGNC:7578): (myosin heavy chain 8) Myosins are actin-based motor proteins that function in the generation of mechanical force in eukaryotic cells. Muscle myosins are heterohexamers composed of 2 myosin heavy chains and 2 pairs of nonidentical myosin light chains. This gene encodes a member of the class II or conventional myosin heavy chains, and functions in skeletal muscle contraction. This gene is predominantly expressed in fetal skeletal muscle. This gene is found in a cluster of myosin heavy chain genes on chromosome 17. A mutation in this gene results in trismus-pseudocamptodactyly syndrome. [provided by RefSeq, Sep 2009]
MYHAS (HGNC:50609): (myosin heavy chain gene cluster antisense RNA) Predicted to enable primary miRNA binding activity. Predicted to be involved in response to muscle activity and skeletal muscle fiber development. Predicted to act upstream of or within with a positive effect on gene expression. Predicted to be located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.03230071).
BP6
Variant 17-10392944-G-C is Benign according to our data. Variant chr17-10392944-G-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 211567.
BS2
High AC in GnomAd4 at 709 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002472.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYH8
NM_002472.3
MANE Select
c.5350C>Gp.Arg1784Gly
missense
Exon 37 of 40NP_002463.2
MYHAS
NR_125367.1
n.76+9737G>C
intron
N/A

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYH8
ENST00000403437.2
TSL:5 MANE Select
c.5350C>Gp.Arg1784Gly
missense
Exon 37 of 40ENSP00000384330.2
MYHAS
ENST00000399342.6
TSL:3
n.76+9737G>C
intron
N/A
MYHAS
ENST00000581304.2
TSL:3
n.52+9737G>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.00467
AC:
711
AN:
152090
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00123
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00308
Gnomad ASJ
AF:
0.00288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00726
Gnomad FIN
AF:
0.00481
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00750
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00530
AC:
1334
AN:
251490
AF XY:
0.00547
show subpopulations
Gnomad AFR exome
AF:
0.00117
Gnomad AMR exome
AF:
0.00199
Gnomad ASJ exome
AF:
0.00417
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00513
Gnomad NFE exome
AF:
0.00764
Gnomad OTH exome
AF:
0.00717
GnomAD4 exome
AF:
0.00756
AC:
11058
AN:
1461892
Hom.:
59
Cov.:
33
AF XY:
0.00740
AC XY:
5384
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.00143
AC:
48
AN:
33480
American (AMR)
AF:
0.00183
AC:
82
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00386
AC:
101
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00596
AC:
514
AN:
86258
European-Finnish (FIN)
AF:
0.00569
AC:
304
AN:
53418
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
0.00860
AC:
9561
AN:
1112012
Other (OTH)
AF:
0.00732
AC:
442
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
815
1629
2444
3258
4073
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
374
748
1122
1496
1870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00466
AC:
709
AN:
152208
Hom.:
3
Cov.:
32
AF XY:
0.00462
AC XY:
344
AN XY:
74418
show subpopulations
African (AFR)
AF:
0.00123
AC:
51
AN:
41520
American (AMR)
AF:
0.00307
AC:
47
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00288
AC:
10
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00686
AC:
33
AN:
4814
European-Finnish (FIN)
AF:
0.00481
AC:
51
AN:
10602
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00750
AC:
510
AN:
68010
Other (OTH)
AF:
0.00331
AC:
7
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
38
76
115
153
191
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00281
Hom.:
0
Bravo
AF:
0.00412
TwinsUK
AF:
0.00782
AC:
29
ALSPAC
AF:
0.00701
AC:
27
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.00570
AC:
49
ExAC
AF:
0.00604
AC:
733
Asia WGS
AF:
0.00202
AC:
7
AN:
3478
EpiCase
AF:
0.00703
EpiControl
AF:
0.00616

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:7
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
Nov 16, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 29565416)

Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

MYH8: PP3, BS2

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:2
Mar 11, 2015
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Hecht syndrome Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease.

May 28, 2019
Mendelics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Inborn genetic diseases Uncertain:1
Mar 31, 2014
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Based on data from the NHLBI Exome Sequencing Project (ESP), the G-allele has an overall frequency of approximately 0.42% (45/10754) total alleles studied. The G-allele was observed in 0.58% (41/7016) European American alleles and in 0.11% (4/3738) African American alleles studied and was not observed in the homozygous state out of 5377 individuals studied. Based on data from the 1000 Genomes Project, the G-allele has an overall frequency of approximately 0.32% (7/2188) and the highest frequency was in 1.82% (2/110) 1.82% Puerto Rican chromosomes studied.The R1784 amino acid is highly conserved among available vertebrate species.This alteration is predicted to be probably damaging with a score of 0.961 (sensitivity: 0.62; specificity: 0.92)This alteration is predicted to be deleterious with a score of 0.000 (conservation: 3.05)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.53
BayesDel_addAF
Benign
0.0054
T
BayesDel_noAF
Pathogenic
0.24
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.54
D
Eigen
Uncertain
0.57
Eigen_PC
Uncertain
0.46
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Uncertain
0.91
D
MetaRNN
Benign
0.032
T
MetaSVM
Uncertain
0.38
D
MutationAssessor
Pathogenic
3.1
M
PhyloP100
0.47
PrimateAI
Pathogenic
0.85
D
PROVEAN
Pathogenic
-4.8
D
REVEL
Pathogenic
0.70
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.027
D
Polyphen
0.99
D
Vest4
0.86
MVP
0.82
MPC
0.82
ClinPred
0.032
T
GERP RS
3.0
Varity_R
0.66
gMVP
0.85
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141215006; hg19: chr17-10296261; COSMIC: COSV67965264; API